✦ LIBER ✦

Monocytic differentiation and synthesis of proteins associated with apoptosis in human leukemia U-937 cells acquiring resistance to Vincristine

✍ Scribed by Panayotis Pantazis; Devasis Chatterjee; Zhiyong Han; James Wyche; Albert DeJesus; Beppino Giovanella

Book ID: 114792083
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 844 KB
Volume: 57
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1996.tb00494.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of apoptosis and differentiati

Induction of apoptosis and differentiation by fludarabine in human leukemia cells (U937): interactions with the macrocyclic lactone bryostatin 1

✍ Vrana, JA; Wang, Z; Rao, AS; Tang, L; Chen, J-H; Kramer, LB; Grant, S 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 166 KB

Signaling Defect in the Activation of Ca

Signaling Defect in the Activation of Caspase-3 and PKCδ in Human TUR Leukemia Cells Is Associated with Resistance to Apoptosis

✍ Gerold Meinhardt; Jeannette Roth; Gabriela Totok; Helge Auner; Bertold Emmerich; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Antisense src expression inhibits tyrosi

Antisense src expression inhibits tyrosine phosphorylation of Shc and its association with Grb2 and Sos which leads to MAP kinase activation in U937 human leukemia cells

✍ Yamaguchi, M; Tanaka, T; Waki, M; Kitanaka, A; Kamano, H; Kubota, Y; Ohnishi, H; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Resistance to 1,25D-induced differentiat

Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor

✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o